Müller Mattia, Schlagenhauf Patricia
University of Zürich, Centre for Travel Medicine, WHO Collaborating Centre for Travellers' Health, Hirschengraben 84, 8001 Zürich, Switzerland.
University of Zürich, Centre for Travel Medicine, WHO Collaborating Centre for Travellers' Health, Hirschengraben 84, 8001 Zürich, Switzerland.
Int J Infect Dis. 2014 May;22:55-64. doi: 10.1016/j.ijid.2013.12.016. Epub 2014 Mar 12.
Since the initial discovery of Plasmodium knowlesi in Malaysia, cases have been reported from several neighbouring countries. Tourism has also resulted in an increasing number of cases diagnosed in Europe, America, and Oceania. In this review we focus on the risk of the travel-associated acquisition of P. knowlesi malaria.
A search of the literature in PubMed was carried out to identify articles and literature on the distribution of P. knowlesi infections in Southeast Asia and details of its acquisition and importation by travellers to other continents. The cut-off date for the search was December 1, 2013. Search words used were: "Plasmodium knowlesi", "Plasmodium knowlesi infections", "Plasmodium knowlesi travellers", "Plasmodium knowlesi prevalence", "Plasmodium knowlesi host", "Plasmodium knowlesi vector" "Plasmodium knowlesi RDT", and "Plasmodium knowlesi Malaysia". Traveller numbers to Malaysia were obtained from the Tourism Malaysia website.
A total of 103 articles were found. Using a selection of these and others identified from the reference lists of the papers, we based our review on a total of 66 articles.
P. knowlesi malaria appears to be the most common malaria species in Malaysian Borneo and is also widely distributed on the Malaysian mainland. Furthermore, locally transmitted cases of P. knowlesi malaria have been reported in Thailand, the Philippines, Vietnam, Singapore, Myanmar, Indonesian Borneo, and Cambodia. Two cases have been reported from non-endemic countries in Asia (Japan and Taiwan) in people with a history of travel to Malaysia and the Philippines. Twelve cases were imported to their home countries by travellers from other continents: two from the USA, two from the Netherlands, two from Germany, and one each from Spain, France, Sweden, Finland, Australia, and New Zealand. In most cases, the infection was associated with a trip to or near forested areas. The symptoms were fever (n=12), headache (n=6), chills (n=6), nausea (n=4), myalgia (n=3), back pain (n=3), abdominal problems (n=1), anorexia (n=2), fatigue (n=2), malaise (n=1), arthralgia (n=1), sore throat (n=1) vomiting (n=2), and jaundice (n=1). All patients were treated successfully with currently available antimalaria treatments. The identification of the pathogen by microscopy can be problematic due to the morphological similarity of P. knowlesi to Plasmodium malariae.
P. knowlesi appears to be a threat not only to the local population in Malaysia, but also to the estimated 25 million annual tourists and occupational travellers to Malaysia, especially those who visit rural, forested areas of the country. The P. knowlesi risk is not limited to Malaysia, and travellers from Southeast Asia presenting with possible malaria should be considered for a diagnostic work-up that includes P. knowlesi.
自从在马来西亚首次发现诺氏疟原虫以来,几个邻国也报告了相关病例。旅游业也导致欧洲、美洲和大洋洲诊断出的病例数量不断增加。在本综述中,我们重点关注与旅行相关的诺氏疟原虫疟疾感染风险。
在PubMed上搜索文献,以确定有关东南亚诺氏疟原虫感染分布以及旅行者将其带入和输入到其他大陆的详细情况的文章和文献。搜索截止日期为2013年12月1日。使用的搜索词为:“诺氏疟原虫”、“诺氏疟原虫感染”、“诺氏疟原虫旅行者”、“诺氏疟原虫流行率”、“诺氏疟原虫宿主”、“诺氏疟原虫媒介”、“诺氏疟原虫快速诊断检测”以及“诺氏疟原虫马来西亚”。前往马来西亚的旅行者人数从马来西亚旅游局网站获取。
共找到103篇文章。通过筛选这些文章以及从论文参考文献列表中识别出的其他文章,我们基于总共66篇文章进行综述。
诺氏疟原虫疟疾似乎是马来西亚婆罗洲最常见的疟原虫种类,在马来西亚大陆也广泛分布。此外,泰国、菲律宾、越南、新加坡、缅甸、印度尼西亚婆罗洲和柬埔寨都报告了本地传播的诺氏疟原虫疟疾病例。亚洲非疟疾流行国家(日本和台湾)报告了两例有前往马来西亚和菲律宾旅行史的病例。来自其他大陆的旅行者将12例病例带回了本国:2例来自美国,2例来自荷兰,2例来自德国,西班牙、法国、瑞典、芬兰、澳大利亚和新西兰各1例。在大多数情况下,感染与前往森林地区或其附近地区的旅行有关。症状包括发热(n = 12)、头痛(n = 6)、寒战(n = 6)、恶心(n = 4)、肌痛(n = 3)、背痛(n = 3)、腹部问题(n = 1)、厌食(n = 2)、疲劳(n = 2)、不适(n = 1)、关节痛(n = 1)、喉咙痛(n = 1)、呕吐(n = 2)和黄疸(n = 1)。所有患者均通过目前可用的抗疟疾治疗成功治愈。由于诺氏疟原虫与三日疟原虫在形态上相似,通过显微镜鉴定病原体可能存在问题。
诺氏疟原虫似乎不仅对马来西亚当地居民构成威胁,而且对每年估计2500万前往马来西亚的游客和职业旅行者构成威胁,尤其是那些前往该国农村森林地区的人。诺氏疟原虫风险不仅限于马来西亚,对于来自东南亚且可能患有疟疾的旅行者,应考虑进行包括诺氏疟原虫检测在内的诊断检查。